Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04201600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Glucose Variability and Cognition in Prediabetes

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 8 more changesShow less
    • Trial completed
    • Final enrollment: 66 participants (planned 30)
    • Primary completion date changed from estimate of Nov 30, 2026 to Sep 16, 2026
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints shortened, about 19 words
    • Site details revised
    • Collaborators: 2 to 3
    • Study description expanded, about 3 words
  2. Primary completion date: Nov 30, 2024 to Nov 30, 2026
    • Study completion date: Dec 31, 2024 to Dec 31, 2026
    v9
  3. 2 versions Re-verified since May 15, 2023, no change to tracked fieldsv7-v8
  4. Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Primary completion date: Nov 30, 2022 to Nov 30, 2024
    • Start date changed from estimate of Nov 1, 2021 to Mar 1, 2022
    • Study completion date: Dec 31, 2022 to Dec 31, 2024
    • Study site revised
  5. Primary completion date: Nov 2022 to Nov 30, 2022
    • Study completion date: Dec 2022 to Dec 31, 2022
    • Start date: Nov 2021 to Nov 1, 2021
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Jun 2021 to Nov 2021
    • Primary completion date: Jun 2022 to Nov 2022
    v4
  2. Primary completion date: Dec 2020 to Jun 2022
    • Start date: Oct 2020 to Jun 2021
    • Study completion date: Dec 2021 to Dec 2022
    v3
  3. Start date: Jan 2020 to Oct 2020
    • Eligibility criteria shortened, about 13 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study examines the association of variability in glucose values over a 10-day period with cognitive function and AD risk markers among individuals with prediabetes, aged 50 or older.
Trial Details
NCT Number NCT04201600
Lead Sponsor University of Maryland, Baltimore
Collaborators: Baltimore VA Medical Center, University of Maryland, Baltimore County, National Institute on Aging (NIA)
Conditions
(from sponsor)		 Glucose Metabolism Disorders (Including Diabetes Mellitus), Cognitive Decline, PreDiabetes, Aging, Alzheimer's Disease
Related terms Alzheimer Disease, Cognitive Dysfunction, Glucose Metabolism Disorders, Prediabetic State
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov